3- (4- (4- (3- chlorophenylamino)- (1,3,5)triazin- 2- yl)pyridin- 2- ylamino)propan- 1- ol
also inhibits CDK2 and CDK5; structure in first source
Also Known As:
CPAT-PAPO cpd
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results